AI assistant
HERBALIFE LTD. — Director's Dealing 2018
Feb 26, 2018
32337_dirs_2018-02-26_1e3383cf-eb5d-4690-bc70-7bd562410106.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-02-22
Reporting Person: JOHNSON MICHAEL (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-22 | Stock Appreciation Rights | $30.44 | A | 244698 | Acquired | 2025-03-02 | Common Stock (244698) | Direct |
| 2018-02-22 | Stock Appreciation Rights | $47.80 | A | 33591 | Acquired | 2026-05-09 | Common Stock (33591) | Direct |
| 2018-02-22 | Stock Appreciation Rights | $57.19 | A | 17655 | Acquired | 2027-02-27 | Common Stock (17655) | Direct |
Footnotes
F1: On March 2, 2015, the reporting person was granted an award of 407,830 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 244,698 SARs which will vest on March 2, 2018.
F2: On May 9, 2016, the reporting person was granted an award of 167,954 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 33,951 SARs which will vest on May 9, 2018.
F3: On February 27, 2017, the reporting person was granted an award of 88,276 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 17,655 SARs which will vest on February 27, 2018.